Drug and Medication Analysis & Statistics in Europe Countries, October 2014

You might be interested in: drug, vaccine, smoking cessation, more »

1-50 of about 1 500 reports

Purchase Reports From Reputable Market Research Publishers

Finland Pharmaceuticals and Healthcare Report Q4 2104

Finland Pharmaceuticals and Healthcare Report Q4 2104

  • $ 1 300
  • Industry report
  • October 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: An ageing population and the subsequent increased consumption of high-value prescription medicines for the treatment of long-term illnesses will place a greate ...

  • Industries : Drug and Medication
  • Countries : Finland
Greece Pharmaceuticals and Healthcare Report Q4 2104

Greece Pharmaceuticals and Healthcare Report Q4 2104

  • $ 1 300
  • Industry report
  • October 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: The pharmaceutical and healthcare industry in Greece will continue to contract over the remainder of 2014. The government will seek to reduce public spending ...

  • Industries : Drug and Medication
  • Countries : Greece
Russia Pharmaceuticals and Healthcare Report Q4 2104

Russia Pharmaceuticals and Healthcare Report Q4 2104

  • $ 1 300
  • Industry report
  • October 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: Russia's cooling of relations with the West is putting pressure on foreign investment in the country. With the EU and the US applying further sanctions, the ...

  • Industries : Drug and Medication
  • Countries : Russian Federation
Czech Republic Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

Czech Republic Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

  • $ 1 300
  • Industry report
  • October 2014
  • by Business Monitor International

BMI View: Our expectations that the Czech Republic would return to moderately positive growth in 2011, before seeing negligible growth in 2012 have been revised downwards, and we now project very low growth ...

  • Industries : Drug and Medication
  • Countries : Czech Republic
Serbia Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

Serbia Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

  • $ 1 300
  • Industry report
  • October 2014
  • by Business Monitor International

BMI View: Serbia’s medium- to-longer term convergence with the wider European industry will stimulate pharmaceutical demand, especially as the country’s economic prospects improve over the coming years. ...

  • Industries : Drug and Medication
  • Countries : Serbia and Montenegro
Spain Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

Spain Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

  • $ 1 300
  • Industry report
  • October 2014
  • by Business Monitor International

BMI View: We believe the Spanish government's decision to implement further austerity measures is a necessary and prudent course of action. The country still has the third highest budget deficit in the ...

  • Industries : Drug and Medication
  • Countries : Spain
Norway Pharmaceuticals and Healthcare Report Q4 2014

Norway Pharmaceuticals and Healthcare Report Q4 2014

  • $ 1 300
  • Industry report
  • October 2014
  • by Business Monitor International

BMI View: While the Norwegian government's pro-generic stance will continue to support growth in the country's off-patent medicines market, we highlight that the loss of market value in the patented drugs ...

  • Industries : Drug and Medication
  • Countries : Norway
Ukraine Pharmaceuticals and Healthcare Report Q4 2014

Ukraine Pharmaceuticals and Healthcare Report Q4 2014

  • $ 1 300
  • Industry report
  • October 2014
  • by Business Monitor International

BMI View: Ukraine is currently experiencing geopolitical tension with its neighbour Russia, which is actively fomenting unrest in the east of Ukraine. In 2014, owing to the severe devaluation of the hryvnia ...

  • Industries : Drug and Medication
  • Countries : Ukraine
Belarus Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

Belarus Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

  • $ 1 300
  • Industry report
  • October 2014
  • by Business Monitor International

BMI View: All indicators point to a period of prolonged economic and political upheaval in Belarus, with the pharmaceutical industry battered by a combination of high inflation and currency devaluation ...

  • Industries : Drug and Medication
  • Countries : Belarus
Slovenia Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

Slovenia Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

  • $ 1 300
  • Industry report
  • September 2014
  • by Business Monitor International

BMI View: In terms of its attractiveness to investors, Slovenia remains a mid-tier pharmaceutical industry within Emerging Europe. While not immune from economic factors and government austerity drives, ...

  • Industries : Drug and Medication
  • Countries : Slovenia
Austria Pharmaceuticals and Healthcare Report Q4 2014

Austria Pharmaceuticals and Healthcare Report Q4 2014

  • $ 1 300
  • Industry report
  • September 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: BMI has upwardly revised its pharmaceutical and healthcare forecasts for Austria, reflecting the country's improving economic prospects and attractiveness of ...

  • Industries : Drug and Medication
  • Countries : Austria
Poland Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

Poland Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

  • $ 1 300
  • Industry report
  • September 2014
  • by Business Monitor International

BMI View: Late-stage revisions to Poland's pharmaceutical reimbursement act have been broadly positive for pharmaceutical industry players operating in this industry . However, the central premise of the ...

  • Industries : Drug and Medication
  • Countries : Poland
Romania Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

Romania Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

  • $ 1 300
  • Industry report
  • September 2014
  • by Business Monitor International

BMI View: We continue to expect Romania's pharmaceutical industry to return to high single-digit growth in 2011 and 2012. However, weaker than expected drug price inflation in Q211 has resulted in a downward ...

  • Industries : Drug and Medication
  • Countries : Romania
France Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

France Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

  • $ 1 300
  • Industry report
  • September 2014
  • by Business Monitor International

BMI View: France is one of the leading global pharmaceutical industry s by size, propped up by its large population of just under 63mn. The French are traditionally fond of patented and branded drugs and ...

  • Industries : Drug and Medication
  • Countries : France
Germany Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

Germany Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

  • $ 1 300
  • Industry report
  • September 2014
  • by Business Monitor International

BMI View: Despite the threat of austerity measures, the government’s focus on cost-containment within the pharmaceuticals and healthcare segment and the impact of generic competition as a result of the ...

  • Industries : Drug and Medication
  • Countries : Germany
Hungary Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

Hungary Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

  • $ 1 300
  • Industry report
  • September 2014
  • by Business Monitor International

BMI View: We continue to project that the Széll Kálmán structural reforms plan, which aims to achieve savings of HUF120bn (US Dollar 580mn) over three years from Hungary’s medicine budget will lead ...

  • Industries : Drug and Medication
  • Countries : Hungary
Italy Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

Italy Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

  • $ 1 300
  • Industry report
  • September 2014
  • by Business Monitor International

BMI View: We believe the Italian government's decision to implement further austerity measures is a necessary and prudent course of action – Italy maintains one of the largest sovereign debt loads in ...

  • Industries : Drug and Medication
  • Countries : Italy
Sweden Pharmaceuticals and Healthcare Report Q4 2014

Sweden Pharmaceuticals and Healthcare Report Q4 2014

  • $ 1 300
  • Industry report
  • September 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: As Sweden's population grows older and demands for healthcare provision increase, the government is facing a concerning scenario of rapidly increasing expenditure ...

  • Industries : Drug and Medication
  • Countries : Sweden
Netherlands Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

Netherlands Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

  • $ 1 300
  • Industry report
  • August 2014
  • by Business Monitor International

BMI View: The Netherlands has a well established pharmaceutical market with strength in vaccines and biologics. As a result, the country has the necessary infrastructure and skilled workforce to be regarded ...

  • Industries : Drug and Medication
  • Countries : Netherlands
Latvia Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

Latvia Pharmaceuticals and Healthcare Industry Update Quarter 4 2011

  • $ 1 300
  • Industry report
  • August 2014
  • by Business Monitor International

BMI View: Latvia's disease profile and relatively low per-capita consumption of pharmaceuticals (compared with the rest of developed Europe) is a clear illustration of the need for innovative medicines. ...

  • Industries : Drug and Medication
  • Countries : Latvia
Czech Republic Pharmaceuticals and Healthcare Industry Update Quarter 3 2011

Czech Republic Pharmaceuticals and Healthcare Industry Update Quarter 3 2011

  • $ 1 300
  • Industry report
  • July 2014
  • by Business Monitor International

BMI View: In response to the expected passage of key drug policy reforms in the Czech Republic, BMI has cut its projections for pharmaceutical industry growth in 2012 to 0.0%, with the prospects of lowe ...

  • Industries : Drug and Medication
  • Countries : Czech Republic
Greece Pharmaceuticals and Healthcare Industry Update Quarter 3 2011

Greece Pharmaceuticals and Healthcare Industry Update Quarter 3 2011

  • $ 1 300
  • Industry report
  • July 2014
  • by Business Monitor International

BMI View: Our view that Greece's pharmaceutical industry is set for a decade of decline remains firmly in play. The list of challenges is sizeable: the combination of price erosion mechanisms; rapid generic ...

  • Industries : Drug and Medication
  • Countries : Greece
Serbia Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

Serbia Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

  • $ 1 300
  • Industry report
  • July 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: The short-term outlook for the Serbian pharmaceutical industry will continue to be clouded by corruption, debts accrued by the country’s health insurance ...

  • Industries : Drug and Medication
  • Countries : Serbia and Montenegro
Moldova Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

Moldova Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

  • $ 1 300
  • Industry report
  • July 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: Full-year trade data for 2011 and Q112 has confirmed that Moldova’s pharmaceutical industry has returned to more normal growth. However, with regional economic ...

  • Industries : Drug and Medication
  • Countries : Moldova, Republic Of
Spain Pharmaceuticals and Healthcare Industry Update Quarter 3 2011

Spain Pharmaceuticals and Healthcare Industry Update Quarter 3 2011

  • $ 1 300
  • Industry report
  • July 2014
  • by Business Monitor International

BMI View: We believe the pharmaceuticals and healthcare segment may be targeted by the government's 2011 cost-containment efforts following the successful implementation of austerity measures in 2010. ...

  • Industries : Drug and Medication
  • Countries : Spain
Russia Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

Russia Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

  • $ 1 300
  • Industry report
  • June 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: The Russian pharmaceutical industry retains vast growth potential and the short- term environment is very positive for both domestic and foreign drugmakers. ...

  • Industries : Drug and Medication
  • Countries : Russian Federation
United Kingdom Pharmaceuticals and Healthcare Industry Update Quarter 3 2011

United Kingdom Pharmaceuticals and Healthcare Industry Update Quarter 3 2011

  • $ 1 300
  • Industry report
  • June 2014
  • by Business Monitor International

BMI View: The UK faces its most uncertain period in a generation, as the Conservative-Liberal Democrat coalition presses ahead with fiscal cutbacks and constitutional reform. Plans to modernise the National ...

  • Industries : Drug and Medication
  • Countries : United Kingdom
Finland Pharmaceuticals and Healthcare Report Q3 2014

Finland Pharmaceuticals and Healthcare Report Q3 2014

  • $ 1 300
  • Industry report
  • June 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: Innovative drugmaker revenues will remain under threat in Finland. The Finnish government is committed to containing rising healthcare costs and despite company ...

  • Industries : Drug and Medication
  • Countries : Finland
Switzerland Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

Switzerland Pharmaceuticals and Healthcare Industry Update Quarter 3 2012

  • $ 1 300
  • Industry report
  • June 2014
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: The period 2011-16 is projection to witness the proliferation of government initiatives supporting the growth of Switzerland's generic medicines industry, which ...

  • Industries : Drug and Medication
  • Countries : Switzerland
Belarus Pharmaceuticals and Healthcare Industry Update Quarter 3 2011

Belarus Pharmaceuticals and Healthcare Industry Update Quarter 3 2011

  • $ 1 300
  • Industry report
  • June 2014
  • by Business Monitor International

BMI View: The pharmaceutical industry in Belarus has significant long-term growth potential, but the country’s economy has entered a period of acute crisis and its long-deferred day of reckoning may ...

  • Industries : Drug and Medication
  • Countries : Belarus
About 2 500 reports

Download Unlimited Documents from Trusted Public Sources

Antibiotic Industry in the UK

  • Infection Report
  • October 2014
    11 pages
  • Antibiotic  

  • United Kingdom  

    Europe  

View report >

Uk - Economic Analysis

September 2014

2 Companies

Read our Company Profiles


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.